Presentation is loading. Please wait.

Presentation is loading. Please wait.

Incidence and Patterns of Adverse Event Onset During the First 60 Days After Ventricular Assist Device Implantation  Elizabeth A. Genovese, BS, Mary Amanda.

Published byÖzge Aladağ Modified over 6 years ago

Similar presentations

Presentation on theme: "Incidence and Patterns of Adverse Event Onset During the First 60 Days After Ventricular Assist Device Implantation  Elizabeth A. Genovese, BS, Mary Amanda."— Presentation transcript:

1 Incidence and Patterns of Adverse Event Onset During the First 60 Days After Ventricular Assist Device Implantation  Elizabeth A. Genovese, BS, Mary Amanda Dew, PhD, Jeffrey J. Teuteberg, MD, Marc A. Simon, MD, MS, Joy Kay, BS, Michael P. Siegenthaler, MD, Jay K. Bhama, MD, Christian A. Bermudez, MD, Kathleen L. Lockard, RN, Steve Winowich, MS, Robert L. Kormos, MD  The Annals of Thoracic Surgery  Volume 88, Issue 4, Pages (October 2009) DOI: /j.athoracsur Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Cumulative incidence of any adverse event during the first 60 days after ventricular assist device implant, controlling for competing risks of transplant, death, and recovery-wean. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Cumulative incidence of major categories of adverse events during the first 60 days after ventricular assist device implant. (A) Cardiac or vascular events. (B) Other organ systems events. (C) Other events. (RV = right ventricular.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Incidence and Patterns of Adverse Event Onset During the First 60 Days After Ventricular Assist Device Implantation  Elizabeth A. Genovese, BS, Mary Amanda."

Similar presentations

Changes in Risk Profile Over Time in the Population of a Pediatric Heart Transplant Program Olaf Reinhartz, MD, Katsuhide Maeda, MD, Bruce A. Reitz, MD,

Changes in Risk Profile Over Time in the Population of a Pediatric Heart Transplant Program Olaf Reinhartz, MD, Katsuhide Maeda, MD, Bruce A. Reitz, MD,
Heart Transplant vs Left Ventricular Assist Device in Heart Transplant-Eligible Patients Matthew L. Williams, MD, Jaimin R. Trivedi, MD, MPH, Kelly C.

Heart Transplant vs Left Ventricular Assist Device in Heart Transplant-Eligible Patients Matthew L. Williams, MD, Jaimin R. Trivedi, MD, MPH, Kelly C.
Fenton H. McCarthy, MD, Dale Kobrin, BA, J. Eduardo Rame, MD, Peter W

Fenton H. McCarthy, MD, Dale Kobrin, BA, J. Eduardo Rame, MD, Peter W
Obese Patients and Mechanical Circulatory Support: Weight Loss, Adverse Events, and Outcomes  Firas Zahr, MD, Elizabeth Genovese, MS, Michael Mathier,

Obese Patients and Mechanical Circulatory Support: Weight Loss, Adverse Events, and Outcomes  Firas Zahr, MD, Elizabeth Genovese, MS, Michael Mathier,
Cumulative Corticosteroid Exposure and Infection Risk After Complex Pediatric Cardiac Surgery  Christopher W. Mastropietro, MD, Renee Barrett, MD, Maria.

Cumulative Corticosteroid Exposure and Infection Risk After Complex Pediatric Cardiac Surgery  Christopher W. Mastropietro, MD, Renee Barrett, MD, Maria.
HeartWare Left Ventricular Assist Device Implantation Through Bilateral Anterior Thoracotomy  Aron Frederik Popov, MD, Morteza Tavakkoli Hosseini, MD,

HeartWare Left Ventricular Assist Device Implantation Through Bilateral Anterior Thoracotomy  Aron Frederik Popov, MD, Morteza Tavakkoli Hosseini, MD,
Risk-Adjusted Prolonged Length of Stay as an Alternative Outcome Measure for Pediatric Congenital Cardiac Surgery  Ming Liu, MS, MA, Charlotte M. Druschel,

Risk-Adjusted Prolonged Length of Stay as an Alternative Outcome Measure for Pediatric Congenital Cardiac Surgery  Ming Liu, MS, MA, Charlotte M. Druschel,
Predicted Risk of Mortality, Transfusion, and Postoperative Outcomes in Isolated Primary Valve Operations  W. Brent Keeling, MD, Jose Binongo, PhD, Eric.

Predicted Risk of Mortality, Transfusion, and Postoperative Outcomes in Isolated Primary Valve Operations  W. Brent Keeling, MD, Jose Binongo, PhD, Eric.
Association of Perioperative Fluid Balance and Adverse Surgical Outcomes in Esophageal Cancer and Esophagogastric Junction Cancer  Shenhai Wei, MD, PhD,

Association of Perioperative Fluid Balance and Adverse Surgical Outcomes in Esophageal Cancer and Esophagogastric Junction Cancer  Shenhai Wei, MD, PhD,
Robert L. Smith, MD, Morley A. Herbert, PhD, Todd M

Robert L. Smith, MD, Morley A. Herbert, PhD, Todd M
Investigating the Causes of Adverse Events

Investigating the Causes of Adverse Events
Severe Pulmonary Valve Regurgitation 40 Years After Blunt Chest Trauma

Severe Pulmonary Valve Regurgitation 40 Years After Blunt Chest Trauma
Age of Transfused Red Cells and Early Outcomes After Cardiac Surgery

Age of Transfused Red Cells and Early Outcomes After Cardiac Surgery
Blood Pressure Control in Continuous Flow Left Ventricular Assist Devices: Efficacy and Impact on Adverse Events  Brent C. Lampert, DO, Chad Eckert, PhD,

Blood Pressure Control in Continuous Flow Left Ventricular Assist Devices: Efficacy and Impact on Adverse Events  Brent C. Lampert, DO, Chad Eckert, PhD,
Bi-Ventricular Circulatory Support With the Abiomed AB5000 System in a Patient With Idiopathic Refractory Ventricular Fibrillation  Li Zhang, MD, MS,

Bi-Ventricular Circulatory Support With the Abiomed AB5000 System in a Patient With Idiopathic Refractory Ventricular Fibrillation  Li Zhang, MD, MS,
Jeffrey G. Gaca, MD, Shubin Sheng, PhD, Mani Daneshmand, MD, J

Jeffrey G. Gaca, MD, Shubin Sheng, PhD, Mani Daneshmand, MD, J
Obese Patients and Mechanical Circulatory Support: Weight Loss, Adverse Events, and Outcomes  Firas Zahr, MD, Elizabeth Genovese, MS, Michael Mathier,

Obese Patients and Mechanical Circulatory Support: Weight Loss, Adverse Events, and Outcomes  Firas Zahr, MD, Elizabeth Genovese, MS, Michael Mathier,
Anomalous Great Cardiac Vein Draining Into the Superior Vena Cava

Anomalous Great Cardiac Vein Draining Into the Superior Vena Cava
John S. Ikonomidis, MD, PhD, Niv Ad, MD, Gabriel S

John S. Ikonomidis, MD, PhD, Niv Ad, MD, Gabriel S
FDA Perspective on Clinical Trial Design for Cardiovascular Devices

FDA Perspective on Clinical Trial Design for Cardiovascular Devices

Similar presentations

Ads by Google